Design of multifunctional non-viral gene vectors to overcome physiological barriers: Dilemmas and strategies

被引:214
作者
Wang, Tao [1 ]
Upponi, Jaydev R. [1 ]
Torchilin, Vladimir P. [1 ]
机构
[1] Northeastern Univ, Ctr Pharmaceut Biotechnol & Nanomed, Boston, MA 02115 USA
关键词
Multifunctional non-viral gene vectors; Delivery barriers; Long-circulation; Targeted delivery; Cytoplamic delivery; Nuclear import; PLASMID-LIPID PARTICLES; ARGININE-RICH PEPTIDES; NUCLEAR-LOCALIZATION SIGNALS; SMALL INTERFERING RNA; TRANSFER IN-VITRO; NANO DEVICE MEND; INTRACELLULAR TRAFFICKING; DELIVERY-SYSTEM; ANTISENSE OLIGONUCLEOTIDES; EXTENDED CIRCULATION;
D O I
10.1016/j.ijpharm.2011.07.013
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Gene-based therapeutics hold great promise for medical advancement and have been used to treat various human diseases with mixed success. However, their therapeutic application in vivo is limited due largely to several physiological barriers. The design of non-viral gene vectors with the ability to overcome delivery obstacles is currently under extensive investigation. These efforts have placed an emphasis on the development of multifunctional vectors able to execute multiple tasks to simultaneously overcome both extracellular and intracellular obstacles. However, the assembly of these different functionalities into a single system to create multifunctional gene vectors faces many conflicts that largely limit the safe and efficient application of lipoplexes and polyplexes in a systemic delivery. In the review, we have described the dilemmas inherent in the design of a viable, non-viral gene vector equipped with multiple functionalities. The strategies directed towards individual delivery barriers are first summarized, followed by a focus on the design of so-called smart multifunctional vectors with the capability to overcome the delivery difficulties of gene medicines, including the so-called the "polycation dilemma", the "PEG dilemma" and the "package and release dilemma". (C) 2011 Elsevier B.V. All rights reserved.
引用
收藏
页码:3 / 20
页数:18
相关论文
共 225 条
[71]   Systemic delivery of siRNA to tumors using a lipid nanoparticle containing a tumor-specific cleavable PEG-lipid [J].
Hatakeyama, Hiroto ;
Akita, Hidetaka ;
Ito, Erika ;
Hayashi, Yasuhiro ;
Oishi, Motoi ;
Nagasaki, Yukio ;
Danev, Radostin ;
Nagayama, Kuniaki ;
Kaji, Noritada ;
Kikuchi, Hiroshi ;
Baba, Yoshinobu ;
Harashima, Hideyoshi .
BIOMATERIALS, 2011, 32 (18) :4306-4316
[72]   A multifunctional envelope type nano device (MEND) for gene delivery to tumours based on the EPR effect: A strategy for overcoming the PEG dilemma [J].
Hatakeyama, Hiroto ;
Akita, Hidetaka ;
Harashima, Hideyoshi .
ADVANCED DRUG DELIVERY REVIEWS, 2011, 63 (03) :152-160
[73]   A pH-sensitive fusogenic peptide facilitates endosomal escape and greatly enhances the gene silencing of siRNA-containing nanoparticles in vitro and in vivo [J].
Hatakeyama, Hiroto ;
Ito, Erika ;
Akita, Hidetaka ;
Oishi, Motoi ;
Nagasaki, Yukio ;
Futaki, Shiroh ;
Harashima, Hideyoshi .
JOURNAL OF CONTROLLED RELEASE, 2009, 139 (02) :127-132
[74]   Associating Gene Therapy with the Human Genome Project [J].
Hayashi, Makoto .
EAST ASIAN SCIENCE TECHNOLOGY AND SOCIETY-AN INTERNATIONAL JOURNAL, 2010, 4 (01) :77-97
[75]   Comparative studies of suppression of malignant cancer cell phenotype by antisense oligo DNA and small interfering RNA [J].
Hiroi, N ;
Funahashi, A ;
Kitano, H .
CANCER GENE THERAPY, 2006, 13 (01) :7-12
[76]   Polyethylenimine/small interfering RNA-mediated knockdown of vascular endothelial growth factor in vivo exerts anti-tumor effects synergistically with Bevacizumab [J].
Hoebel, Sabrina ;
Koburger, Ivette ;
John, Matthias ;
Czubayko, Frank ;
Hadwiger, Philipp ;
Vornlocher, Hans-Peter ;
Aigner, Achim .
JOURNAL OF GENE MEDICINE, 2010, 12 (03) :287-300
[77]   Photochemical internalisation in drug and gene delivery [J].
Hogset, A ;
Prasmickaite, L ;
Selbo, PK ;
Hellum, M ;
Engesæter, BO ;
Bonsted, A ;
Berg, K .
ADVANCED DRUG DELIVERY REVIEWS, 2004, 56 (01) :95-115
[78]   Light-induced adenovirus gene transfer, an efficient and specific gene delivery technology for cancer gene therapy [J].
Hogset, A ;
Engesæter, BO ;
Prasmickaite, L ;
Berg, K ;
Fodstad, O ;
Mælandsmo, GM .
CANCER GENE THERAPY, 2002, 9 (04) :365-371
[79]   Pegylated immuno-lipopolyplexes: A novel non-viral gene delivery system for liver cancer therapy [J].
Hu, Yurong ;
Li, Kun ;
Wang, Lei ;
Yin, Shasha ;
Zhang, Zhenzhong ;
Zhang, Yun .
JOURNAL OF CONTROLLED RELEASE, 2010, 144 (01) :75-81
[80]   Exon Skipping and Duchenne Muscular Dystrophy Therapy: Selection of the Most Active U1 snRNA-Antisense Able to Induce Dystrophin Exon 51 Skipping [J].
Incitti, Tania ;
De Angelis, Fernanda G. ;
Cazzella, Valentina ;
Sthandier, Olga ;
Pinnaro, Chiara ;
Legnini, Ivano ;
Bozzoni, Irene .
MOLECULAR THERAPY, 2010, 18 (09) :1675-1682